Go to content
Go to search
Go to menu

Newsroom
Publications
Press room
Participant area

Français
English

Submit a project

Who are we?
Who are we?
ANRS Infectious emerging diseases (MIE), autonomous agency of Inserm, facilitates, evaluates, coordinates and funds research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging and re-emerging infectious diseases.

The agency in brief
A central role in infectious diseases research for over 35 years

Mission and strategy
Supporting research to prevent, understand and treat infectious diseases

Leading, funding and structuring research
ANRS MIE three majors levels of action

Organisation and governance
ANRS MIE is an agency operating under the specific status of an autonomous agency within Inserm.

Scientific commitments and values
Patient associations, next generation of scientists, quality and ethical approach, open science

Emergence programme
Exceptional procedure for responding to emerging or re-emerging epidemics
Research
Research
Our agency funds, coordinates, evaluates and facilitates research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging infectious diseases.

Diseases and pathogens
Learn more about the diseases and pathogens covered by our research

Research projects
Information on the projects we fund

Scientific facilitation groups
Our workgroups bring together researchers and representatives of civil society

Innovation Committee
Guiding and advising innovative project leaders
Infrastructures
Infrastructures
The agency supports a number of research platforms and networks to federate and help shape research in its field

Research platforms
National and international research platforms supported by the agency and designed for the scientific community

Thematic networks
Clinical research networks and networks of young researchers

Data and samples
Access to data and biological collections from research promoted by the agency
Partnerships
Partnerships
The agency is a member of various networks and forges partnerships with national and international associations, organisations and initiatives

The ANRS Emerging infectious diseases International Network
Partner sites, international global health research platforms, ad hoc partnerships

Partnerships and initiatives
WHO, Ministry of Europe and Foreign Affairs, Global Health EDCTP3 Joint Undertaking, structuring networks

International structuring projects
Strategic international projects and capacity-building programmes

WHO filovirus CORC
Fighting epidemics: ANRS MIE leads WHO filovirus CORC

Patient associations
Collaboration with community stakeholders
Funding
Funding
Each year, the agency offers two calls for generic projects and calls for thematic projects. Some are jointly carried out with other research players

All calls for proposals
Agency's current, forthcoming and completed calls for proposals

Winning projects and candidates
Find out the list of calls for projects previously funded by the agency

Start programme
Find out the Start programme, here to support and guide the next generation of scientific researchers

Newsroom
Publications
Press room
Participant area
- Français
- English

Submit a project

Search

Homepage
Guinea

actus de l’anrs

Last updated on 27 March 2024

Share:

Share on Twitter
Share on Linkedin

Primary objective

To assess the effect of BBIBP-CorV vaccine on the humoral immune response in adults, one month after full vaccination for SARS-CoV-2.

In brief
You are a researcher ?
You have taken part in this study ?

ANRS0002S CoviCompare-P

ANRS 0406s PrevHPV-TG : Prevalence of HPV and STI infections

Pratical information

Newsroom
Contact us
Join us
Site map

Legal

Legal information
Personal data and cookies
Accessibility

Newsletter

Subscribe to receive our latest news :

By subscribing, you agree that the ANRS MIE may use your email address to send you the newsletter.